Foulkes WD - Search Results

1

Mixed ovarian germ cell tumor in a BRCA2 mutation carrier.

Hamel N, Wong N, Alpert L, Galvez M, Foulkes WD. Hamel N, et al. Among authors: foulkes wd. Int J Gynecol Pathol. 2007 Apr;26(2):160-4. doi: 10.1097/01.pgp.0000228142.52054.0f. Int J Gynecol Pathol. 2007. PMID: 17413983

2

Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.

Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, Faucher MC, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Goss P, Anderson D, Larsson C, Narod SA, Futreal PA. Phelan CM, et al. Nat Genet. 1996 May;13(1):120-2. doi: 10.1038/ng0596-120. Nat Genet. 1996. PMID: 8673090

3

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women.

Karp SE, Tonin PN, Bégin LR, Martinez JJ, Zhang JC, Pollak MN, Foulkes WD. Karp SE, et al. Among authors: foulkes wd. Cancer. 1997 Aug 1;80(3):435-41. doi: 10.1002/(sici)1097-0142(19970801)80:3<435::aid-cncr11>3.0.co;2-y. Cancer. 1997. PMID: 9241077

4

CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein.

Sun S, Pollock PM, Liu L, Karimi S, Jothy S, Milner BJ, Renwick A, Lassam NJ, Hayward NK, Hogg D, Narod SA, Foulkes WD. Sun S, et al. Among authors: foulkes wd. Int J Cancer. 1997 Nov 14;73(4):531-6. doi: 10.1002/(sici)1097-0215(19971114)73:4<531::aid-ijc13>3.0.co;2-c. Int J Cancer. 1997. PMID: 9389568 Free article.

5

Survival of patients with breast cancer and BRCA1 mutations.

Foulkes WD, Wong N, Rozen F, Brunet JS, Narod SA. Foulkes WD, et al. Lancet. 1998 May 2;351(9112):1359-60. doi: 10.1016/S0140-6736(05)79091-7. Lancet. 1998. PMID: 9643825 No abstract available.

6

BRCA mutations and survival in breast cancer.

Foulkes WD, Wong N, Brunet JS, Narod SA. Foulkes WD, et al. J Clin Oncol. 1998 Sep;16(9):3206-8. doi: 10.1200/JCO.1998.16.9.3206. J Clin Oncol. 1998. PMID: 9738598 No abstract available.

7

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA. Tonin PN, et al. Among authors: foulkes wd. Am J Hum Genet. 1998 Nov;63(5):1341-51. doi: 10.1086/302099. Am J Hum Genet. 1998. PMID: 9792861 Free PMC article.

8

BRCA1 and BRCA2: penetrating the clinical arena.

Foulkes WD. Foulkes WD. Lancet. 1998 Oct 24;352(9137):1325-6. doi: 10.1016/S0140-6736(05)60738-6. Lancet. 1998. PMID: 9802263 No abstract available.

9

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.

Foulkes WD, Wong N, Brunet JS, Bégin LR, Zhang JC, Martinez JJ, Rozen F, Tonin PN, Narod SA, Karp SE, Pollak MN. Foulkes WD, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2465-9. Clin Cancer Res. 1997. PMID: 9815648

10

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.

Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S. Warner E, et al. J Natl Cancer Inst. 1999 Jul 21;91(14):1241-7. doi: 10.1093/jnci/91.14.1241. J Natl Cancer Inst. 1999. PMID: 10413426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

737 results

Search Page